U.S. market Closed. Opens in 2 hours 22 minutes

RYZB | RayzeBio, Inc. Common Stock Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-31
RevenueN/AN/AN/A
Cost of RevenueN/AN/AN/A
Gross ProfitN/AN/AN/A
Operating Expenses72.12M39.38M6.92M
Selling, General & Admin10.94M5.50M1.08M
Research & Development61.18M33.88M5.84M
Other Operating ExpensesN/A9.67MN/A
Operating Income-72.12M-39.38M-6.92M
Other Expenses / Income3.52M9.94M5.00K
Before Tax Income-68.60M-29.44M-6.92M
Income Tax ExpensesN/A-265.00KN/A
Net Income-68.60M-29.44M-6.92M
Interest ExpensesN/AN/AN/A
Basic Shares Outstanding39.22M40.31M40.31M
Diluted Shares Outstanding39.22M40.31M40.31M
EBITDA-70.59M-38.92M-6.71M
EBITDA Margin0.00%0.00%0.00%
EBIT-68.60M-29.71M-6.92M
EBIT Margin0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙